Moa Fransson Email

CEO . Genagon Theraputics

Current Roles

Employees:
12
Revenue:
$2.4M
About
Genagon Therapeutics drug development is based on ground-breaking discoveries of unstudied proteins and their life cycles in innate immune cells. Genagon was founded in 2015 and is growing a strong and broad patent portfolio with opportunities for internal development and future partnerships. The company is supported financially by among others, Beijer Ventures and Almi Invest.
Genagon Theraputics Address

Stockholm, null
SWE
Genagon Theraputics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.